Jennison Associates’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
95,772
+403
| +0.4% | +$4.7K | ﹤0.01% | 474 |
|
|
2025
Q1 | $709K | Sell |
95,369
-82,489
| -46% | -$613K | ﹤0.01% | 512 |
|
|
2024
Q4 | $1.07M | Sell |
177,858
-53,673
| -23% | -$322K | ﹤0.01% | 486 |
|
|
2024
Q3 | $1.19M | Buy |
231,531
+53,908
| +30% | +$276K | ﹤0.01% | 473 |
|
|
2024
Q2 | $643K | Buy |
177,623
+2,856
| +2% | +$10.3K | ﹤0.01% | 529 |
|
|
2024
Q1 | $561K | Buy |
174,767
+31,547
| +22% | +$101K | ﹤0.01% | 553 |
|
|
2023
Q4 | $702K | Buy |
143,220
+8,595
| +6% | +$42.1K | ﹤0.01% | 530 |
|
|
2023
Q3 | $734K | Sell |
134,625
-21,167
| -14% | -$115K | ﹤0.01% | 500 |
|
|
2023
Q2 | $1.05M | Buy |
155,792
+3,378
| +2% | +$22.7K | ﹤0.01% | 478 |
|
|
2023
Q1 | $1.35M | Sell |
152,414
-42,622
| -22% | -$376K | ﹤0.01% | 473 |
|
|
2022
Q4 | $1.49M | Buy |
195,036
+20,745
| +12% | +$158K | ﹤0.01% | 455 |
|
|
2022
Q3 | $1.24M | Buy |
+174,291
| New | +$1.24M | ﹤0.01% | 487 |
|
|
2019
Q3 | – | Sell |
-285,744
| Closed | -$13.8M | – | 634 |
|
|
2019
Q2 | $13.8M | Buy |
+285,744
| New | +$13.8M | 0.01% | 406 |
|